The treatment of helicobacter pylori-associated erosive lesions of gastroduodenal zone with the use of interactive learning technologies and rebamipide in young men
https://doi.org/10.31146/1682-8658-ecg-169-9-27-31
Abstract
Purpose of the study. To evaluate the effectiveness of interactive teaching technologies and rebamipids in the complex therapy of erosive lesions of the gastroduodenal zone in young men.
Material and research methods. Two groups of patients were examined. The observation group included 36 recruits with HP-associated gastritis with erosion (HSE) and duodenitis with erosion (DSE). Comprehensive treatment was used as a treatment: standard first-line triple therapy with the inclusion of rebamipide 100 mg 3 times a day for 14 days and interactive therapeutic training. The comparison group consisted of 18 patients with HP-associated GSE and DsE who received standard triple eradication therapy also for 14 days. The average age of the examined patients in the observation group was 21.0 ± 0.7 years, the comparison group was 20.1 ± 0.7 years.
Results. The inclusion of Helicobacter pylori-associated gastritis and duodenitis with erosion of rebamipide and interactive learning technologies into the treatment regimen resulted in more effective relief of pain syndrome and dyspeptic manifestations in conscripts, restoration of mucus-forming and acid-producing functions of the stomach; to lower blood cortisol levels; reduce the degree of morphological activity of inflammation. There is a more effective eradication of Helicobacter pylori (91.7%) and epithelization of erosion (97.2%) in comparison with the standard scheme (88.9% and 94.4%, respectively). The use of interactive teaching technologies allowed to increase the level of medical activity and hygienic literacy (96.0% of recruits changed their diet, the nature of nutrition — 88.0%). The level of psycho-emotional status significantly improved after the treatment.
Conclusion Combined therapy using rebamipide and interactive therapeutic training is effective in erosive lesions of the gastroduodenal zone in young men and increases patient adherence to treatment and leads to stabilization of psycho- emotional status.
About the Authors
E. R. KorobeynikovaRussian Federation
Elena R. Korobeynikova, gastroenterologist, Izhevsk, 426008, Russia
E. Yu. Shkatova
Russian Federation
Elena Yu. Shkatova, head of the Department of disaster medicine and life safety, associate Professor, MD, Izhevsk, 426008, Russia
References
1. Korobeynikova E. R., Shkatova E. Yu. Health condition of draftees with gastroduodenal erosions. Vyatka medical messenger, 2017, no. 3, pp. 57–62.
2. Yanul A. N. Erosions of the stomach and duodenum in conscripts. Military medicine, 2015, no. 1, pp. 74–80.
3. Lazebnik L. B., Tkachenko E. I., Abdulganiyeva D. I. VI national guidelines for the diagnosis and treatment of acid-related and helicobacter pylori-associated diseases (VI Moscow agreement). Experimental and Clinical Gastroenterology. 2017;138(02):03–21.
4. Plotnikova E. Yu., Gracheva, T. Yu. Erosive and ulcerative lesions of the gastrointestinal tract and prostaglandins: a problematic Duo. Directory of outpatient physician, 2016, no. 4, pp. 32–37.
5. Yakovenko E. P., Agafonova N. A. Ivanov A. N. et al. Cytoprotector, rebamipide in the treatment of inflammatory and erosive-ulcerative lesions of the gastrointestinal tract. Therapeutic archive, 2016, vol. 88, no. 4, pp. 88–92.
6. Nishizawa T., Nishizawa Y., Yahagi N., et al. Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and metaanalysis. J Gastroenterol Hepatol, 2014, vol. 29, no. 4, pp. 20–4. doi:10.1111/jgh.12769.120.
7. Myshkina L. V., Shkatova, E. Yu., Popova N. M. The use of nursing education programs to improve the quality of life of patients with peptic ulcer. Health, demography, ecology of the Finno-Ugric peoples, 2017, no. 4, pp. 14–17.
Review
For citations:
Korobeynikova E.R., Shkatova E.Yu. The treatment of helicobacter pylori-associated erosive lesions of gastroduodenal zone with the use of interactive learning technologies and rebamipide in young men. Experimental and Clinical Gastroenterology. 2019;(9):27-31. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-169-9-27-31